Sardu Celestino, Gatta Gianluca, Pieretti Gorizio, Viola Luigi, Sacra Cosimo, Di Grezia Graziella, Musto Lanfranco, Minelli Salvatore, La Forgia Daniele, Capodieci Mariangela, Galiano Alessandro, Vestito Angela, De Lisio Angela, Pafundi Pia Clara, Sasso Ferdinando Carlo, Cappabianca Salvatore, Nicoletti Gianfranco, Paolisso Giuseppe, Marfella Raffaele
Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
Breast Unit, Department of Clinical and Experimental Internship, University of Campania "Luigi Vanvitelli," Naples, Italy; Department of Imaging, University of Naples, Naples, Italy.
JACC Cardiovasc Imaging. 2021 Feb;14(2):426-438. doi: 10.1016/j.jcmg.2020.08.028. Epub 2020 Oct 28.
This study sought to determine whether the breast gland adipose tissue is associated with different rates of major adverse cardiac events (MACEs) in pre-menopausal women.
To our knowledge, no study investigated the impact of breast adipose tissue infiltration on MACEs in pre-menopausal women.
Prospective multicenter cohort study conducted on pre-menopausal women >40 years of age without cardiovascular disease and breast cancer at enrollment. The study started in January 2000 and ended in January 2009, and the end of the follow-up for the evaluation of MACEs was in January 2019. Participants underwent mammography to evaluate breast density and were divided into 4 groups according to their breast density. The primary endpoint was the probability of a MACE at 10 years of follow-up in patients staged for different breast deposition/adipose tissue deposition.
The propensity score matching divided the baseline population of 16,763 pre-menopausal women, leaving 3,272 women according to the category of breast density from A to D. These women were assigned to 4 groups of the study according to baseline breast density. At 10 years of follow-up, we had 160 MACEs in group 1, 62 MACEs in group 2, 27 MACEs in group 3, and 16 MACEs in group 4. MACEs were predicted by the initial diagnosis of lowest breast density (hazard ratio: 3.483; 95% confidence interval: 1.476 to 8.257). Further randomized clinical trials are needed to translate the results of the present study into clinical practice. The loss of ex vivo breast density models to study the cellular/molecular pathways implied in MACE is another study limitation.
Among pre-menopausal women, a higher evidence of adipose tissue at the level of breast gland (lowest breast density, category A) versus higher breast density shows higher rates of MACEs. Therefore, the screening mammography could be proposed in overweight women to stage breast density and to predict MACEs. (Breast Density in Pre-menopausal Women Is Predictive of Cardiovascular Outcomes at 10 Years of Follow-Up [BRECARD]; NCT03779217).
本研究旨在确定绝经前女性的乳腺脂肪组织是否与主要不良心血管事件(MACE)的不同发生率相关。
据我们所知,尚无研究调查乳腺脂肪组织浸润对绝经前女性MACE的影响。
对入组时年龄大于40岁、无心血管疾病和乳腺癌的绝经前女性进行前瞻性多中心队列研究。研究始于2000年1月,结束于2009年1月,评估MACE的随访终点为2019年1月。参与者接受乳腺钼靶检查以评估乳腺密度,并根据乳腺密度分为4组。主要终点是不同乳腺沉积/脂肪组织沉积分期患者在随访10年时发生MACE的概率。
倾向评分匹配将16763名绝经前女性的基线人群进行划分,根据乳腺密度从A到D的类别,留下3272名女性。这些女性根据基线乳腺密度被分配到研究的4组中。在随访10年时,第1组有160例MACE,第2组有62例,第3组有27例,第4组有16例。MACE可通过最初诊断为最低乳腺密度来预测(风险比:3.483;95%置信区间:1.476至8.257)。需要进一步的随机临床试验将本研究结果转化为临床实践。缺乏用于研究MACE中所涉及的细胞/分子途径的离体乳腺密度模型是本研究的另一个局限性。
在绝经前女性中,与较高乳腺密度相比,乳腺水平的脂肪组织证据更多(最低乳腺密度,A类)表明MACE发生率更高。因此,对于超重女性可建议进行乳腺钼靶筛查以确定乳腺密度分期并预测MACE。(绝经前女性的乳腺密度可预测随访10年时的心血管结局[BRECARD];NCT03779217)